Importance of functional and metabolic impairments in the characterization of the C-26 murine model of cancer cachexia.
about
Discerning primary and secondary factors responsible for clinical fatigue in multisystem diseasesDepletion of white adipose tissue in cancer cachexia syndrome is associated with inflammatory signaling and disrupted circadian regulationTumor growth increases neuroinflammation, fatigue and depressive-like behavior prior to alterations in muscle function.Distinct behaviour of sorafenib in experimental cachexia-inducing tumours: the role of STAT3Oral Treatment with the Ghrelin Receptor Agonist HM01 Attenuates Cachexia in Mice Bearing Colon-26 (C26) TumorsStorage Conditions and Passages Alter IL-6 secretion in C26 adenocarcinoma cell lines.Ubiquinol reduces muscle wasting but not fatigue in tumor-bearing miceMetalloproteinase expression is altered in cardiac and skeletal muscle in cancer cachexiaPre-treatment effects of peripheral tumors on brain and behavior: neuroinflammatory mechanisms in humans and rodents.Ibuprofen ameliorates fatigue- and depressive-like behavior in tumor-bearing mice.The emerging role of skeletal muscle oxidative metabolism as a biological target and cellular regulator of cancer-induced muscle wastingDiaphragm and ventilatory dysfunction during cancer cachexia.Cancer cachexia decreases specific force and accelerates fatigue in limb muscle.Characterization of the male ApcMin/+ mouse as a hypogonadism model related to cancer cachexia.Tranilast administration reduces fibrosis and improves fatigue resistance in muscles of mdx dystrophic mice.Pantoprazole blocks the JAK2/STAT3 pathway to alleviate skeletal muscle wasting in cancer cachexia by inhibiting inflammatory response.Therapeutic Approaches in Mitochondrial Dysfunction, Proteolysis, and Structural Alterations of Diaphragm and Gastrocnemius in Rats With Chronic Heart Failure.Baicalin, a component of Scutellaria baicalensis, alleviates anorexia and inhibits skeletal muscle atrophy in experimental cancer cachexia.Pharmacological strategies in lung cancer-induced cachexia: effects on muscle proteolysis, autophagy, structure, and weakness.New cancer cachexia rat model generated by implantation of a peritoneal dissemination-derived human stomach cancer cell line.Inhibition of the renin-angiotensin system improves physiological outcomes in mice with mild or severe cancer cachexia.Specific targeting of TGF-β family ligands demonstrates distinct roles in the regulation of muscle mass in health and disease.Hypothalamic food intake regulation in a cancer-cachectic mouse model.Disrupted Skeletal Muscle Mitochondrial Dynamics, Mitophagy, and Biogenesis during Cancer Cachexia: A Role for Inflammation.Modeling human cancer cachexia in colon 26 tumor-bearing adult mice.A shared mechanism of muscle wasting in cancer and Huntington's disease.Physiological characterization of a mouse model of cachexia in colorectal liver metastases.Skeletal Muscle Function During the Progression of Cancer Cachexia in the Male ApcMin/+ Mouse.Treating cachexia using soluble ACVR2B improves survival, alters mTOR localization, and attenuates liver and spleen responses.Leukemia inhibitory factor via the Toll-like receptor 5 signaling pathway involves aggravation of cachexia induced by human gastric cancer-derived 85As2 cells in rats
P2860
Q26866364-59E4CDD3-AAC7-4FD5-BA81-065532AD0257Q27312755-57A0BF5E-D649-41E0-9468-07E3149BF012Q27331924-5CB69737-1A3E-4350-926B-798E153A547DQ28542391-7AA552FA-979C-4B1F-831A-2C8222B6B8FAQ33755034-55262FDA-04FC-4D75-8ED7-5B1570EB0C87Q35104200-44CC4985-7CF0-48E3-86C7-73301E9C2ECFQ35186185-C2E08065-5D5C-4752-B1F5-52094378CADDQ35958613-B8A09C6F-BCD3-4C1F-A181-CF6871E61B52Q36052673-96AA604C-30FB-4C38-BABC-AE592BD291E3Q36373115-C7EE0ABB-AB25-407F-95B9-745C01B760C8Q36901945-A807828D-C9B6-4D2F-9BA7-A5D3D703A8F4Q36945130-833DA550-F7EA-4907-908C-51A0FD873566Q37002408-F093C353-0B62-417A-9B89-8D4ACFB15490Q37392800-8FEFCCFE-DCC4-4AAB-A92F-0DA44D27C93AQ37539643-FB67D7C4-A1FA-479E-BE64-9E9EF6F5C91BQ38704047-23D96457-0812-40C8-A1CB-8C55D17D15A4Q38946714-1E717BD4-5E3F-4C41-8F06-EACEE4A7527EQ38959117-A7CA4A1A-2FB6-478F-9234-3739F0E89536Q39016673-BC5B298C-A12C-48D5-AB3E-18A1B6C17E2DQ39042463-F110ACE0-56C8-4103-A2D1-6D88420F06A3Q39189453-65DEB754-164B-484B-B850-9FEDFEBE68A7Q40162611-343EB5EA-F751-414C-82BB-54E2374D2361Q40580808-3BDBAACF-DD7A-4835-A023-142C6FDE4EA0Q41146515-9DEFF439-4FE6-4B19-92CD-605F315BE3F6Q42229082-46518312-9937-417B-ADCD-B0FD8175FB6DQ43131306-54A5FA65-3ADA-49DB-B875-68CB2ABBFF90Q44387417-99F9DD08-EE1F-425F-8092-1F65576FC81DQ47419257-B6F32DAA-5051-41F7-BBA2-9753094B3478Q55432588-B85E6579-2D8B-494F-B4BF-58712FDDD124Q58582637-6D4F9527-23B4-4273-87D3-198A22ABEA1C
P2860
Importance of functional and metabolic impairments in the characterization of the C-26 murine model of cancer cachexia.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Importance of functional and m ...... rine model of cancer cachexia.
@ast
Importance of functional and m ...... rine model of cancer cachexia.
@en
type
label
Importance of functional and m ...... rine model of cancer cachexia.
@ast
Importance of functional and m ...... rine model of cancer cachexia.
@en
prefLabel
Importance of functional and m ...... rine model of cancer cachexia.
@ast
Importance of functional and m ...... rine model of cancer cachexia.
@en
P2093
P2860
P356
P1476
Importance of functional and m ...... rine model of cancer cachexia.
@en
P2093
Annabel Chee
Jennifer Trieu
Timur Naim
P2860
P304
P356
10.1242/DMM.008839
P577
2012-03-22T00:00:00Z